Omega Healthcare Investors (STU:WX4) Cyclically Adjusted Revenue per Share: €4.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:WX4 Omega Healthcare Investors Inc STU:WX4
72 GF Score
Price €42.02
GF Value €34.60
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Cyclically Adjusted Revenue per Share?

Omega Healthcare Investors STU:WX4 -0.33% 72 Cyclically Adjusted Revenue per Share is €4.27 as of Jun. 2026. GuruFocus rates STU:WX4 with a GF Score™ of 72/100 and a GF Value™ of €34.60 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Omega Healthcare Investors's adjusted revenue per share for the three months ended in Jun. 2026 was €0.901. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €4.27 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Omega Healthcare Investors's average Cyclically Adjusted Revenue Growth Rate was -0.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Omega Healthcare Investors was 6.80% per year. The lowest was -20.30% per year. And the median was 1.45% per year.

As of today (2026-08-06), Omega Healthcare Investors's current stock price is €42.02. Omega Healthcare Investors's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €4.27. Omega Healthcare Investors's Cyclically Adjusted PS Ratio of today is 9.84.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omega Healthcare Investors was 11.19. The lowest was 5.42. And the median was 8.04.


Omega Healthcare Investors  (STU:WX4) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Omega Healthcare Investors's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=42.02/4.27
=9.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Omega Healthcare Investors was 11.19. The lowest was 5.42. And the median was 8.04.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Omega Healthcare Investors Cyclically Adjusted Revenue per Share Related Terms


Omega Healthcare Investors Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Cyclically Adjusted Revenue per Share Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.96 4.47 4.41 4.61 4.12

Omega Healthcare Investors Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.12 4.12 4.12 4.22 4.27

STU:WX4 vs DOC, AHR, CTRE: Cyclically Adjusted Revenue per Share Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors Cyclically Adjusted PS Ratio vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's Cyclically Adjusted PS Ratio falls into.


STU:WX4
72GF Score
Omega Healthcare Investors Inc STU:WX4
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Omega Healthcare Investors's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.901/333.9520*333.9520
=0.901

Current CPI (Jun. 2026) = 333.9520.

Omega Healthcare Investors Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.981 241.428 1.357
201612 1.085 241.432 1.501
201703 1.051 243.801 1.440
201706 1.015 244.955 1.384
201709 0.892 246.819 1.207
201712 0.900 246.524 1.219
201803 0.859 249.554 1.150
201806 0.903 251.989 1.197
201809 0.903 252.439 1.195
201812 0.911 251.233 1.211
201903 0.927 254.202 1.218
201906 0.904 256.143 1.179
201909 0.935 256.759 1.216
201912 0.974 256.974 1.266
202003 0.976 258.115 1.263
202006 0.971 257.797 1.258
202009 0.433 260.280 0.556
202012 0.916 260.474 1.174
202103 0.959 264.877 1.209
202106 0.876 271.696 1.077
202109 0.971 274.310 1.182
202112 0.896 278.802 1.073
202203 0.914 287.504 1.062
202206 0.951 296.311 1.072
202209 0.994 296.808 1.118
202212 0.563 296.797 0.633
202303 0.838 301.836 0.927
202306 0.938 305.109 1.027
202309 0.886 307.789 0.961
202312 0.855 306.746 0.931
202403 0.870 312.332 0.930
202406 0.898 314.175 0.955
202409 0.903 315.301 0.956
202412 0.928 315.605 0.982
202503 0.868 319.799 0.906
202506 0.808 322.561 0.837
202509 0.861 324.800 0.885
202512 0.870 324.054 0.897
202603 0.886 330.213 0.896
202606 0.901 333.952 0.901

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €4.27 mean?
Omega Healthcare Investors (STU:WX4) has a Cyclically Adjusted Revenue per Share of €4.27 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Omega Healthcare Investors and its competitors.
Is Omega Healthcare Investors' Cyclically Adjusted Revenue per Share too high?
Omega Healthcare Investors' current Cyclically Adjusted Revenue per Share is €4.27. Overall, Omega Healthcare Investors has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Cyclically Adjusted Revenue per Share compare to DOC and AHR?
Omega Healthcare Investors' Cyclically Adjusted Revenue per Share of €4.27 can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a REITs company?
A good Cyclically Adjusted Revenue per Share depends on the REITs industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Omega Healthcare Investors and its competitors. Omega Healthcare Investors's current Cyclically Adjusted Revenue per Share is €4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (STU:WX4) is currently considered Modestly Overvalued. The stock's GF Value™ is €34.60, compared to a current price of €42.02 — trading 21.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €4.27. Omega Healthcare Investors' overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Omega Healthcare Investors (STU:WX4), the current Cyclically Adjusted Revenue per Share is €4.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (STU:WX4) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of €42.02 is trading 21.4% above its estimated GF Value™ of €34.60. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for STU:WX4:

  • Cyclically Adjusted Revenue per Share: €4.27
  • GF Value™: €34.60 vs. price of €42.02 (21.4% above fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the STU:WX4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
72GF Score

Get the complete analysis for STU:WX4

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.02
Price
€34.60
GF Value